Scientific Reports · 2021 · 49 citations · 9 references
Veterinary MedicineImmunologyInfectious DiseasesClinical EpidemiologyEpidemiologyInfectious Disease EpidemiologyBlood Group SerologyHealthcare-associated Infection PreventionHealthcare-associated InfectionsInfectious Disease Risk FactorsAbo Blood Group AntigensAbo Blood Group TypingHealthcare-associated Infection RiskInfectious Disease Morbidity Patterns
The COVID-19 pandemic has affected more than 100 million cases and caused immense burdens on governments and healthcare systems worldwide. Since its emergence in December 2019, research has been focused on treating the infected, identifying those at risk and preventing spread. There is currently no known biological biomarker that predicts the risk of infection. Several studies emerged suggesting an association between ABO blood group and the risk of COVID-19 infection. In this study, we used retrospective observational data in Bahrain to investigate the association between ABO blood group and risk of infection, as well as susceptibility to severe ICU-requiring infection. We found a higher risk associated with blood group B, and a lower risk with blood group AB. No association was observed between blood group and the risk of a severe ICU-requiring infection. We extended the analysis to study the association by antibodies; anti-a (blood groups B and O) and anti-b (blood groups A and O). No association between antibodies and both risk of infection or susceptibility to severe infection was found. The current study, along with the variation in blood group association results, indicates that blood group may not be an ideal biomarker to predict risk of COVID-19 infection.
9
Human susceptibility and resistance to Norwalk virus infection
Lisa C. Lindesmith, Christine L. Moe, Séverine Marionneau‐Lambot et al. · Nature Medicine · 2003 · 1.1K citations
Relationship between the ABO Blood Group and the COVID-19 Susceptibility
Jiao Zhao, Yan Yang, Han-Ping Huang et al. · medRxiv · 2020 · 454 citations · Full text
Blood type and outcomes in patients with COVID-19
Christopher A. Latz, Charles DeCarlo, Laura T. Boitano et al. · Annals of Hematology · 2020 · 363 citations · Full text